Gaudium IVF Board Meeting on Nov 12 for Q2 FY27 Results

Gaudium IVF and Women Health Limited has announced that its Board of Directors will convene on November 12, 2026. The primary agenda items include the consideration and approval of the Unaudited Standalone and Consolidated Financial Results for the quarter and half-year ended September 30, 2026. The meeting will also involve taking on record the Auditor’s Limited Review Report. The company will submit the outcome of the board meeting and the auditor's report as per SEBI Listing Regulations. Additionally, the trading window for designated persons will remain closed until 48 hours after the declaration of these results, as per the Insider Trading Regulations.